These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2007 related items for PubMed ID: 26093190

  • 21. Plan A: postabortion contraception.
    Micks E, Prager S.
    Clin Obstet Gynecol; 2014 Dec; 57(4):751-62. PubMed ID: 25254920
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.
    Varney SJ, Guest JF.
    Pharmacoeconomics; 2004 Dec; 22(17):1141-51. PubMed ID: 15612832
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparison of contraceptive method chosen by women with and without a recent history of induced abortion.
    Madden T, Secura GM, Allsworth JE, Peipert JF.
    Contraception; 2011 Dec; 84(6):571-7. PubMed ID: 22078185
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Impact of long-acting reversible contraception on return for repeat abortion.
    Rose SB, Lawton BA.
    Am J Obstet Gynecol; 2012 Jan; 206(1):37.e1-6. PubMed ID: 21944222
    [Abstract] [Full Text] [Related]

  • 28. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R, Sheeder J, Arango N, Teal SB, Tocce K.
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Twenty-four-month continuation of reversible contraception.
    O'Neil-Callahan M, Peipert JF, Zhao Q, Madden T, Secura G.
    Obstet Gynecol; 2013 Nov; 122(5):1083-1091. PubMed ID: 24104781
    [Abstract] [Full Text] [Related]

  • 32. [Weight variation in users of the levonorgestrel-releasing intrauterine system, of the copper IUD and of medroxyprogesterone acetate in Brazil].
    Yela DA, Monteiro IM, Bahamondes LG, Del Castillo S, Bahamondes MV, Fernandes A.
    Rev Assoc Med Bras (1992); 2006 Nov; 52(1):32-6. PubMed ID: 16622536
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 35. Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant.
    Deese J, Philip N, Lind M, Ahmed K, Batting J, Beksinska M, Edward VA, Louw CE, Onono M, Palanee-Phillips T, Smit JA, Baeten JM, Donnell D, Mastro TD, Mugo NR, Nanda K, Rees H, Morrison C.
    Sex Transm Infect; 2021 Jun; 97(4):249-255. PubMed ID: 33208512
    [Abstract] [Full Text] [Related]

  • 36. Progestin-only contraceptives: effects on weight.
    Lopez LM, Ramesh S, Chen M, Edelman A, Otterness C, Trussell J, Helmerhorst FM.
    Cochrane Database Syst Rev; 2016 Aug 28; 2016(8):CD008815. PubMed ID: 27567593
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review.
    Birgisson NE, Zhao Q, Secura GM, Madden T, Peipert JF.
    J Womens Health (Larchmt); 2015 May 28; 24(5):349-53. PubMed ID: 25825986
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 101.